Edition:
United States

Clinigen Group PLC (CLINC.L)

CLINC.L on London Stock Exchange

1,126.00GBp
20 Oct 2017
Change (% chg)

1.00 (+0.09%)
Prev Close
1,125.00
Open
1,126.00
Day's High
1,129.00
Day's Low
1,119.00
Volume
330,075
Avg. Vol
448,527
52-wk High
1,175.00
52-wk Low
695.00

Chart for

About

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources... (more)

Overall

Beta: 0.62
Market Cap(Mil.): £1,299.07
Shares Outstanding(Mil.): 115.37
Dividend: 3.40
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.38 16.52
EPS (TTM): -- -- --
ROI: -- 2.39 11.32
ROE: -- 3.35 15.18

Clinigen boost unlicensed drugs business with Quantum takeover

LONDON Britain's Clinigen Group on Wednesday agreed to buy Quantum Pharma for 150.3 million pounds ($200 million), bringing together two companies that specialize in the supply of unlicensed medicines to doctors and hospitals.

Sep 13 2017

Clinigen boost unlicensed drugs business with Quantum takeover

LONDON, Sept 13 Britain's Clinigen Group on Wednesday agreed to buy Quantum Pharma for 150.3 million pounds ($200 million), bringing together two companies that specialise in the supply of unlicensed medicines to doctors and hospitals.

Sep 13 2017

BRIEF-Clinigen updates on recommended offer for Quantum Pharma Plc

* CO, QUANTUM PHARMA AGREED TERMS OF RECOMMENDED ACQUISITION BY CLINIGEN OF ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF QUANTUM FOR £150.3 MILLION​ Source text for Eikon: Further company coverage:

Sep 13 2017

BRIEF-Clinigen confirms submitted takeover proposal for Quantum Pharma

* SAYS NOTES ANNOUNCEMENT RELEASED BY QUANTUM PHARMA, CONFIRMS THAT HAS SUBMITTED INDICATIVE PROPOSAL REGARDING POSSIBLE OFFER FOR QUANTUM PHARMA

Aug 17 2017

BRIEF-Quantum Pharma confirms bid from Clinigen

* POSSIBLE OFFER TO BE SATISFIED THROUGH COMBINATION OF NEW ORDINARY SHARES IN CLINIGEN AND CASH

Aug 16 2017

BRIEF-Quantum Pharma confirms proposal from Clinigen Group on possible offer

* CONFIRMS THAT RECEIVED INDICATIVE PROPOSAL FROM CLINIGEN GROUP PLC REGARDING POSSIBLE OFFER FOR COMPANY

Aug 16 2017

BRIEF-Clinigen receives EC approval for updates to cardioxane product information

* RECEIVES EC APPROVAL FOR UPDATES TO CARDIOXANE PRODUCT INFORMATION Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Aug 08 2017

Earnings vs. Estimates